Care of the treatment naive patient with hcv infection and mild liver disease

15
Care of the Treatment- Naive Patient With HCV Infection and Mild Liver Disease

description

Care of the treatment naive patient with hcv infection and mild liver disease

Transcript of Care of the treatment naive patient with hcv infection and mild liver disease

Page 1: Care of the treatment naive patient with hcv infection and mild liver disease

Care of the Treatment-Naive Patient With HCV Infection and

Mild Liver Disease

Page 2: Care of the treatment naive patient with hcv infection and mild liver disease
Page 3: Care of the treatment naive patient with hcv infection and mild liver disease

Case: 50-Year-Old Man With HCV Infection

Page 4: Care of the treatment naive patient with hcv infection and mild liver disease

Patient Evaluation

Page 5: Care of the treatment naive patient with hcv infection and mild liver disease

FibroScan

Page 6: Care of the treatment naive patient with hcv infection and mild liver disease

Would You Recommend Treatment for This Patient?

Page 7: Care of the treatment naive patient with hcv infection and mild liver disease

2 Second-Generation DAA Agents Approved by the FDA

Page 8: Care of the treatment naive patient with hcv infection and mild liver disease

IFN Is Not Necessarily a Deal Breaker

Page 9: Care of the treatment naive patient with hcv infection and mild liver disease

Simeprevir + Sofusbuvir?

Page 10: Care of the treatment naive patient with hcv infection and mild liver disease

The US HCV-Infected Population Has a High Rate of Comorbidity

Page 11: Care of the treatment naive patient with hcv infection and mild liver disease

Managing the Patient Who Opts to Wait for Newer Therapies

Page 12: Care of the treatment naive patient with hcv infection and mild liver disease

Abbreviations

Page 13: Care of the treatment naive patient with hcv infection and mild liver disease

Abbreviations (cont)

Page 14: Care of the treatment naive patient with hcv infection and mild liver disease

References

Page 15: Care of the treatment naive patient with hcv infection and mild liver disease

References (cont)


acad.ro  · Web viewWord Bioetics Day, Grigore T. Popa University of Medicine and Pharmacy Iasi, presentations – Exclusions of the patient with HCV and mild/moderate fibrosis.

acad.ro  · Web viewWord Bioetics Day, Grigore T. Popa University of Medicine and Pharmacy Iasi, presentations – Exclusions of the patient with HCV and mild/moderate fibrosis.

Care of the Treatment-naive Patient With HCV/HIV Coinfection

Care of the Treatment-naive Patient With HCV/HIV Coinfection

Naive Mnemonics

Naive Mnemonics

Naive blindness

Naive blindness

HCV protease inhibitors in the treatment of naive and … · SVR, considered virologic cure, was defined as HCV RNA

HCV protease inhibitors in the treatment of naive and … · SVR, considered virologic cure, was defined as HCV RNA

Naive Physics

Naive Physics

Therapeutic Strategies for HCV Non-Genotype 1 · 2015-06-22 · Genotype 3 HCV Treatment-Naive Pts • Not recommended: – PegIFN/RBV for 24-48 wks – Monotherapy with pegIFN, RBV,

Therapeutic Strategies for HCV Non-Genotype 1 · 2015-06-22 · Genotype 3 HCV Treatment-Naive Pts • Not recommended: – PegIFN/RBV for 24-48 wks – Monotherapy with pegIFN, RBV,

Naive ML Overview

Naive ML Overview

MRTS Naive SystemWM

MRTS Naive SystemWM

Naive art1

Naive art1

Naive Bayes

Naive Bayes

Care of the Treatment-Naive Patient With HCV Infection and Mild Liver Disease

Care of the Treatment-Naive Patient With HCV Infection and Mild Liver Disease

Naive Bayes 1, Naive Bayes and Text Classication I

Naive Bayes 1, Naive Bayes and Text Classication I

NAIVE - Summer 2015

NAIVE - Summer 2015

Post EASL 2012 HCV/Koinfektionen · 2012. 8. 26. · Ribavirin dose modification in treatment-naive and previously treated patients who received telaprevir combination treatment:

Post EASL 2012 HCV/Koinfektionen · 2012. 8. 26. · Ribavirin dose modification in treatment-naive and previously treated patients who received telaprevir combination treatment:

Jurnal Naive Bayes

Jurnal Naive Bayes

Summary Report of SEIA and HCV Assessment of PT Agrolestari …r) - Summary Report of SEIA... · 2017-03-28 · Eight HCV were identified: HCV 1 (HCV 1.1, HCV 1.2 and HCV 1.3), HCV

Summary Report of SEIA and HCV Assessment of PT Agrolestari …r) - Summary Report of SEIA... · 2017-03-28 · Eight HCV were identified: HCV 1 (HCV 1.1, HCV 1.2 and HCV 1.3), HCV

Histoire singulière de l’hépatite C - CUNEA · 2020-04-01 · HCV seropositive, HCV RNA detectable HCV seropositive, HCV RNA undetectable HCV seronegative 12.8% 1.6% 0.7% 19.8%

Histoire singulière de l’hépatite C - CUNEA · 2020-04-01 · HCV seropositive, HCV RNA detectable HCV seropositive, HCV RNA undetectable HCV seronegative 12.8% 1.6% 0.7% 19.8%

HIV/HCV Coinfection News – HCV Protease Inhibitors

HIV/HCV Coinfection News – HCV Protease Inhibitors

Spam Filtering with Naive Bayes - Which Naive Bayes? · PDF fileSpam Filtering with Naive Bayes – Which Naive Bayes? ∗ Vangelis Metsis † Institute of Informatics and Telecommunications,

Spam Filtering with Naive Bayes - Which Naive Bayes? · PDF fileSpam Filtering with Naive Bayes – Which Naive Bayes? ∗ Vangelis Metsis † Institute of Informatics and Telecommunications,